Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab.

Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab. — المؤلف: Rickard, Frances — BMJ case reports 20181015

المؤلف
Rickard, Frances
النشر
BMJ case reports 20181015
الموضوعات
Aged؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Computed Tomography Angiography؛ Continuous Positive Airway Pressure؛ Cough؛ Diagnosis, Differential؛ Dyspnea